Literature DB >> 2343075

Changes in GABA content and turnover in discrete regions of rat brain after systemic administration of caerulein.

K Nakamura1, T Matsumoto, M Hirano, H Uchimura.   

Abstract

The effects of systemically injected caerulein, a cholecystokinin octapeptide analogue, on GABA content and turnover have been studied in various regions of rat brain. Caerulein decreased GABA levels in the nucleus accumbens, tuberculum olfactorium and substantia nigra and diminished GABA turnover rates in the striatum, nucleus accumbens and substantia nigra, as estimated from the rate of GABA accumulation after inhibition of GABA transaminase by aminooxyacetic acid (AOAA). These results indicate the effect of caerulein on the utilization of GABA in specific cerebral regions and suggest that the GABAergic system is involved in the mechanism of action of peripherally administered caerulein.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2343075     DOI: 10.1007/bf02253721

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  26 in total

1.  The effects of antipsychotics on the turnover rate of GABA and acetylcholine in rat brain nuclei.

Authors:  E Marco; C C Mao; D L Cheney; A Revuelta; E Costa
Journal:  Nature       Date:  1976-11-25       Impact factor: 49.962

2.  Differential effects of n-dipropylacetate and amino-oxyacetic acid on gamma-aminobutyric acid levels in discrete areas of rat brain.

Authors:  M J Iadarola; A Raines; K Gale
Journal:  J Neurochem       Date:  1979-11       Impact factor: 5.372

3.  Effects of systemically administered cholecystokinin-octapeptide on local cerebral metabolism.

Authors:  G Lucignani; L J Porrino; C A Tamminga
Journal:  Eur J Pharmacol       Date:  1984-05-18       Impact factor: 4.432

4.  Peptide-monoamine coexistence: studies of the actions of cholecystokinin-like peptide on the electrical activity of midbrain dopamine neurons.

Authors:  L R Skirboll; A A Grace; D W Hommer; J Rehfeld; M Goldstein; T Hökfelt; B S Bunney
Journal:  Neuroscience       Date:  1981       Impact factor: 3.590

5.  Immunohistochemical localization of cholecystokinin- and gastrin-like peptides in the brain and hypophysis of the rat.

Authors:  J J Vanderhaeghen; F Lotstra; J De Mey; C Gilles
Journal:  Proc Natl Acad Sci U S A       Date:  1980-02       Impact factor: 11.205

6.  Effects of muscimol and picrotoxin on single unit activity of substantia nigra neurons.

Authors:  B L Waszczak; N Eng; J R Walters
Journal:  Brain Res       Date:  1980-04-21       Impact factor: 3.252

7.  Effect of diazepam and pentobarbital on aminooxyacetic acid-induced accumulation on GABA.

Authors:  D Pericić; J R Walters; T N Chase
Journal:  J Neurochem       Date:  1977-11       Impact factor: 5.372

8.  Mass fragmentographic determination of gamma-aminobutyric acid and glutamic acid in discrete amygdaloid nuclei of rat brain.

Authors:  K Nakamura; T Matsumoto; M Hirano; H Kagoshima; T Kuroki; H Yao; H Uchimura; T Nakahara
Journal:  J Neurochem       Date:  1987-06       Impact factor: 5.372

9.  Degradation of cholecystokinin-like peptides by a crude rat brain synaptosomal fraction: a study by high pressure liquid chromatography.

Authors:  M Deschodt-Lanckman; N D Bui; M Noyer; J Christophe
Journal:  Regul Pept       Date:  1981-04

10.  Long-lasting effect of systemically administrated caerulein on monoaminergic neuronal pathways in rat brain.

Authors:  T Kuroki; T Matsumoto; M Hirano; H Kagoshima; H Yao; H Uchimura; K Nakamura; T Nakahara
Journal:  Neuropeptides       Date:  1987 Feb-Mar       Impact factor: 3.286

View more
  2 in total

1.  An investigation of the origin of extracellular GABA in rat nucleus accumbens measured in vivo by microdialysis.

Authors:  S E Smith; T Sharp
Journal:  J Neural Transm Gen Sect       Date:  1994

2.  Effects of flumazenil on cholecystokinin-tetrapeptide-induced panic symptoms in healthy volunteers.

Authors:  J Bradwejn; D Koszycki; A Couëtoux du Tertre; M Paradis; M Bourin
Journal:  Psychopharmacology (Berl)       Date:  1994-03       Impact factor: 4.530

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.